Matthew A. Greenwood - 09 Mar 2026 Form 4 Insider Report for ProFrac Holding Corp. (ACDC)

Role: Chief Commercial Officer
Signature: /s/ Steven Scrogham, Attorney-in-Fact
Issuer symbol: ACDC
Transactions as of: 09 Mar 2026
Net transactions value: $0
Form type: 4
Filing time: 11 Mar 2026, 16:15:08 UTC
Previous filing: 01 Apr 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Greenwood Matthew A	Chief Commercial Officer	C/O PROFRAC HOLDING CORP., 333 SHOPS BOULEVARD, SUITE 301, WILLOW PARK	/s/ Steven Scrogham, Attorney-in-Fact	11 Mar 2026	0001922681

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ACDC	Class A common stock, par value $0.01 per share	Award		+41,790	+29%	$0.000000^*	184,607	09 Mar 2026	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents 34,743 and 7,047 shares of Company common stock issued under performance share awards granted to the reporting person on March 28, 2025 (the "March 2025 Grant") and March 31, 2023 (the "March 2023 Grant"), respectively. The awards are subject to performance-vesting restrictions based on EBITDA, free cash flow and other performance criteria for the performance period from January 1, 2025 to December 31, 2025. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the Company's Board of Directors. The shares of the March 2025 Grant will vest equally on March 28, 2026, March 28, 2027 and March 28, 2028, subject to the reporting person's continued service and good standing through each applicable vesting date. The shares of the March 2023 Grant will vest on March 31, 2026.

Content

Represents 34,743 and 7,047 shares of Company common stock issued under performance share awards granted to the reporting person on March 28, 2025 (the "March 2025 Grant") and March 31, 2023 (the "March 2023 Grant"), respectively. The awards are subject to performance-vesting restrictions based on EBITDA, free cash flow and other performance criteria for the performance period from January 1, 2025 to December 31, 2025. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the Company's Board of Directors. The shares of the March 2025 Grant will vest equally on March 28, 2026, March 28, 2027 and March 28, 2028, subject to the reporting person's continued service and good standing through each applicable vesting date. The shares of the March 2023 Grant will vest on March 31, 2026.